Cone Biopsy of the Cervix in India: CKC vs LEEP, Fertility and Cost

• A cone biopsy removes a cone-shaped piece of the cervix to diagnose and treat high-grade pre-cancer (CIN 2/3, AIS) or very early (microinvasive) cervical cancer.
• There are two techniques: LEEP (a wire loop under local anaesthesia, quick and office-based) and cold-knife conization or CKC (a scalpel under general or spinal anaesthesia). LEEP suits most squamous lesions; CKC is preferred for AIS or suspected microinvasion.
• For appropriately treated pre-cancer with clear margins, cure rates are roughly 85-95 percent, and most women never go on to develop cervical cancer.
• Cone biopsy removes part of the cervix and modestly raises the risk of preterm birth in a later pregnancy - this is manageable with the right antenatal monitoring and, if needed, a cervical stitch.
• In India it is free at government tertiary hospitals and under Ayushman Bharat PMJAY; private cost is roughly Rs 8,000-25,000 for LEEP and Rs 25,000-80,000 for CKC.
• Follow-up matters as much as the procedure: co-testing (Pap plus HPV) at set intervals for at least five years catches any recurrence early.

A cone biopsy, also called cervical conization, removes a cone-shaped wedge of cervix for examination under a microscope and, in the same step, to treat the abnormal area. The cone is shaped to include the outer cervix you can see (the ectocervix), the transformation zone where almost all cervical pre-cancers begin, and a length of the canal that runs up into the cervix (the endocervical canal). Taking a cone, rather than a small punch biopsy, lets the pathologist see the full extent and depth of the abnormal cells and check that the edges are clear.

A cone biopsy does two jobs at once. First, it is diagnostic: it gives a much larger tissue sample than a Colposcopy in India: Why It's Needed, How It's Done, and What It Costs punch biopsy, so the pathologist can grade the change accurately and rule out a hidden invasive cancer. Second, it is therapeutic: by removing the abnormal area with a rim of normal tissue around it (usually 3 mm or more at all edges, called a clear margin), it often cures the pre-cancer outright.

The depth of the cone is tailored to the lesion. A shallow cone (under 1 cm) suits a small lesion on the outer cervix; a standard cone (1-1.5 cm) covers most situations; a deeper cone (over 1.5 cm) is used when the abnormality reaches high into the canal, as it often does with glandular pre-cancer. The more cervix removed, the more thorough the diagnosis - but also the greater the effect on a future pregnancy, which is why surgeons aim to remove all the disease while preserving as much healthy cervix as possible.

Cone biopsy sits within the wider story of cervical cancer prevention. It is the step a woman may reach after an abnormal Pap or HPV test leads to colposcopy, and most cervical pre-cancer traces back to persistent high-risk HPV infection. Preventing that infection in the first place - through the HPV vaccine and regular screening - is expected to steadily reduce how often cone biopsy is needed in India.

Your gynaecologist will recommend a cone biopsy when a colposcopy and small biopsy are not enough to settle the diagnosis or to remove the disease safely. The usual reasons are listed below. A cone biopsy is never the first thing that happens - it follows screening and colposcopy with a directed biopsy, so the decision is based on tissue findings, not a single abnormal smear.

An important reassurance: most cone biopsies are done for pre-cancer, which is not cancer. It is an abnormal area that, left untreated for years, could progress - and the cone biopsy interrupts that path. Only a minority are done for very early (microinvasive) cancer.

A cone biopsy is usually not the right step for low-grade change (CIN 1) on its own in a young woman, which often clears by itself and is watched with repeat testing; for a small, fully visible high-grade lesion that can be treated by ablation (freezing or thermal); for cervical cancer beyond the earliest stage, which needs radical surgery or radiation; or during pregnancy, except when cancer is genuinely suspected, because bleeding and pregnancy risks are higher.

In the Indian context, cervical cancer remains the second commonest cancer in women after breast cancer, though incidence is slowly falling as screening coverage widens through VIA (visual inspection with acetic acid), Pap cytology and HPV testing. Cone biopsy is widely available at tertiary centres; smaller towns may have LEEP at the district hospital while CKC and complex cases are referred to a medical college or regional cancer centre.

There are two ways to take a cone, and the choice is one of the main decisions you and your doctor make together. Neither is simply 'better' - each suits different situations.

LEEP (loop electrosurgical excision procedure, also called LLETZ) uses a thin wire loop heated by an electric current to slice out the tissue. It is done under local anaesthesia (a paracervical block), takes 10-20 minutes, can be an office or day-care procedure, causes little bleeding because the current seals small vessels, and removes less cervix. Its limitation is heat 'artifact' at the cut edges, which can occasionally blur the pathologist's view of the margins. For more on the loop technique, see our dedicated guide to the LEEP procedure in India.

Cold-knife conization (CKC) uses a surgical scalpel - 'cold' meaning no electric current is used for the cut itself. It is done in an operating theatre under general or spinal anaesthesia, takes 30-60 minutes, and gives a single, clean specimen with no heat damage at the edges. That clean margin is exactly why CKC is preferred when accurate margins really matter - for AIS, for suspected microinvasion, and when a deep cone is needed. The trade-offs are anaesthesia, slightly more bleeding, a longer recovery and higher cost.

A simple way to think about it: LEEP is usually first choice for squamous CIN 2/3, especially in younger women who want to preserve fertility, because it removes less cervix and avoids anaesthesia. CKC is chosen when the diagnosis hinges on a perfect margin (AIS, possible early cancer), when the lesion sits high in the canal, or when disease has come back after a previous LEEP. Both have broadly similar cure rates of about 85-95 percent for the right indication.

Knowing the sequence ahead of time tends to make the day far less frightening. Both techniques start the same way: you lie back with your feet supported (the lithotomy position), the area is cleaned, and a speculum gives the doctor a clear view of the cervix. A dye - dilute acetic acid and often Lugol's iodine (Schiller's test) - is painted on so abnormal areas stand out and the surgeon can be sure the cone includes all of them.

For LEEP: the cervix is numbed with a local injection (lignocaine, usually with adrenaline to limit bleeding) at a few points around it; you wait two to three minutes for it to work. The surgeon then sweeps the heated loop through the abnormal area in one smooth pass, sometimes adding a deeper pass in the canal (the 'top-hat' technique) if needed. Any oozing is sealed with a ball electrode or a paste such as Monsel's solution. You rest for half an hour and usually go home within the hour.

For CKC: after anaesthesia, the surgeon may place stay sutures and inject adrenaline solution to reduce bleeding, then cuts a single cone of tissue with the scalpel. The specimen is carefully marked at the 12-o'clock position so the pathologist can orient it and read every margin. Bleeding is controlled with stitches (sometimes Sturmdorf sutures), cautery or a haemostatic agent, and a gauze pack may be left in for about 24 hours. An endocervical curettage - a scrape of the canal above the cone - is often taken to check for any remaining disease, especially with AIS.

If you are Rh-negative, ask whether you need anti-D immunoglobulin; this is part of standard care in many situations involving cervical bleeding, much as it is in Rh-negative pregnancy. The tissue goes to the lab and results typically take 5-10 days, after which you will have a follow-up visit to discuss what was found and any next steps.

Recovery is usually straightforward, but the cervix needs several weeks to heal fully. After LEEP most women are back to office work in one to three days; after CKC, allow a few days and up to two to three weeks for full recovery. Mild cramping for a day or two is normal and settles with paracetamol or ibuprofen.

Expect some bleeding and discharge. Light bleeding or spotting can last one to three weeks. After LEEP there is often a brown or black discharge from the Monsel's paste, and bleeding can briefly increase around day 5-10 when the scab (eschar) at the site comes away - this is normal. Some intermittent spotting between periods in the weeks afterwards is expected as the cervix heals, and is not a cause for alarm on its own.

To let the cervix heal, avoid the following for about four to six weeks: sex, tampons or a menstrual cup, douching, swimming, tub baths, heavy lifting and strenuous exercise. Use sanitary pads rather than anything internal. Many women feel a little tender for the first time they have sex afterwards; some light bleeding after sex once you resume can happen as healing completes, but heavy or persistent bleeding should be checked.

Serious complications are uncommon, but it helps to know the warning signs. Go to the nearest hospital emergency department - taking your procedure records with you - if you have any of the following:

For women in their reproductive years, this is often the biggest worry - and it deserves an honest, balanced answer. A cone biopsy does not affect your ovaries or hormones, and the great majority of women conceive and carry a healthy pregnancy afterwards. There is no fixed waiting period to try, beyond letting the cervix heal over six to twelve weeks, though it is wise to discuss timing with your doctor.

The one real consideration is cervical insufficiency in a later pregnancy - a weakened or shortened cervix that can lead to a mid-trimester loss or an early (preterm) birth. The risk rises with how much cervix was removed: roughly 5-10 percent after LEEP and 10-15 percent after CKC, and higher again with very deep cones or more than one procedure. This is precisely why, when fertility is a priority and it is clinically safe, surgeons favour LEEP and the shallowest adequate cone.

The good news is that this risk is very manageable with the right antenatal care. In a pregnancy after cone biopsy, your obstetrician will usually book you early at a unit able to handle higher-risk pregnancies, monitor your cervical length by transvaginal scan (often every 2-4 weeks from about 16 to 24 weeks), and may offer vaginal progesterone. If the cervix shortens, or after a deep CKC or repeat procedures, a cervical cerclage - a stitch to support the cervix - can be placed. Knowing the signs of preterm labour and presenting early matters too; where preterm birth becomes likely, antenatal corticosteroids help the baby's lungs mature.

Bring your cone biopsy details to your first antenatal visit - the technique used (LEEP or CKC), the cone depth, the year and any complications. If it was done elsewhere, request the pathology report and operative note. With this information and a clear monitoring plan, women who have had a cone biopsy can plan pregnancy with confidence.

In India the cost depends on the technique, the setting and whether you are covered by a government scheme. At government tertiary hospitals - AIIMS centres, JIPMER, PGI Chandigarh, Tata Memorial Hospital Mumbai, regional cancer centres and major medical colleges - the procedure is free or heavily subsidised for eligible women. In the private sector, expect roughly Rs 8,000-25,000 for LEEP and Rs 25,000-80,000 for CKC, plus the cost of investigations, histopathology and follow-up.

Several schemes can cover all or most of the cost. Ayushman Bharat PMJAY offers up to Rs 5 lakh per family per year at empanelled hospitals for eligible lower-income households and includes cervical pre-cancer procedures. State schemes add further cover - Tamil Nadu CMCHIS, Karnataka's Aarogya Karnataka, Andhra Pradesh YSR Aarogyasri, Telangana Aarogyasri, Rajasthan's Chiranjeevi Yojana, Maharashtra MJPJAY and Kerala KASP, among others. Organised-sector workers may use ESI; central government employees and pensioners, CGHS. Most private health insurance covers cone biopsy as a day-care or inpatient procedure.

Access is best in cities and at major centres. If you live in a smaller town, LEEP is often available at the district hospital, while CKC and complex cases - suspected microinvasion or AIS - are usually referred to a medical college or regional cancer centre. The Family Planning Association of India (FPAI) offers LEEP at subsidised rates at some clinics, and tele-consultation with a tertiary centre can help plan a referral and avoid unnecessary travel.

Looking ahead, wider use of the HPV vaccine - including India's affordable indigenous Cervavac - together with stronger screening is expected to reduce the future need for procedures like cone biopsy by preventing the high-risk HPV infections that cause cervical pre-cancer in the first place.

Overall, serious complications are uncommon - under about 5 percent for LEEP and 5-10 percent for CKC - and most are minor and easily managed in experienced hands.

The commonest issue is bleeding. A little is normal, and a brief increase around day 5-10 after LEEP (when the scab separates) is expected. Heavier bleeding is more likely after CKC and is treated with pressure, cautery or stitches; transfusion is rarely needed. Infection occurs in under 1 percent, helped by preventive antibiotics, and is treated promptly if fever or a foul discharge appears.

Two longer-term issues deserve a mention. Cervical stenosis - narrowing of the canal from scar tissue - is rare (under 2 percent after LEEP, 2-5 percent after CKC) and can cause absent or very painful periods; it is treated by gently dilating the canal. Cervical insufficiency in a later pregnancy is covered in the fertility section above. Finally, if the margins of the cone come back positive (disease at the cut edge), about a quarter to a third of women have some residual disease, and you will be offered closer follow-up or a repeat procedure - which is why margin status guides the next step.

Choosing an experienced gynaecologist or gynaecological oncologist, the right technique for your situation, an adequate-but-not-excessive cone and good follow-up together keep complications low and outcomes excellent.

Follow-up is not optional - it is what turns a successful procedure into long-term safety. It begins with the histopathology result, usually at one to two weeks, which confirms the grade, whether the margins are clear, and the result of any endocervical curettage.

If the margins are clear, the cone biopsy is considered curative for that lesion and you move to surveillance. For CIN 2/3 with clear margins, that usually means co-testing (a Pap plus an HPV test together) at about 6 and 12 months, then yearly for at least five years before returning to routine intervals; co-testing is more sensitive than a Pap alone for spotting any recurrence. AIS and microinvasive cancer need closer, longer surveillance because they can recur, and some women with AIS choose a hysterectomy once their family is complete.

If the margins are positive, you will be guided to repeat colposcopy in a few months, a repeat cone, or in some cases a hysterectomy - depending on the grade and your circumstances. Where more definitive surgery is chosen, it is often done by a minimally invasive route; our guide to laparoscopy in women explains what that involves.

Two lifestyle points genuinely change your odds. First, attend every follow-up visit - loss to follow-up is one of the biggest avoidable risks after treatment. Second, if you smoke or use any form of tobacco, stopping lowers your risk of recurrence and progression; quitting support is available and worthwhile, as covered in our guide to tobacco cessation for women in India. It is also reasonable to discuss HPV vaccination with your doctor, as it may lower the chance of recurrence after treatment in some women.

Anxiety around surveillance visits is very common and entirely understandable. If it weighs on you, support is available - iCall (9152987821) offers multilingual emotional support, and many cancer centres have counsellors and patient groups. The reality worth holding onto is that most women treated for cervical pre-cancer never develop cervical cancer.

• World Health Organization - Cervical cancer (key facts, screening and treatment)
• WHO guidelines for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
• ACOG - Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors
• NHS - Colposcopy and treatment of abnormal cervical cells (LLETZ, cone biopsy)
• ICMR - Consensus Document for Management of Cancer Cervix
• National Health Mission (MoHFW), India - Operational Framework: Management of Common Cancers (cervical cancer screening and treatment)